Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

NCT04305496 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

818

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced (Inoperable) or Metastatic Breast Cancer

Interventions

DRUG: Fulvestrant
DRUG: Capivasertib
DRUG: Placebo

Sponsor

AstraZeneca